Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · IEX Real-Time Price · USD
0.524
-0.022 (-4.05%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $19.09 million as of July 2, 2024. Its market cap has decreased by -13.61% in one year.
Market Cap
19.09M
Enterprise Value
-11.35M
1-Year Change
-13.61%
Ranking
Category
Stock Price
$0.52
Market Cap Chart
Since April 13, 2017, Forte Biosciences's market cap has decreased from $213.50M to $19.09M, a decrease of -91.06%. That is a compound annual growth rate of -28.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 19.10M | -36.12% |
| Dec 29, 2023 | 29.90M | 42.38% |
| Dec 30, 2022 | 21.00M | -33.54% |
| Dec 31, 2021 | 31.60M | -93.24% |
| Dec 31, 2020 | 467.20M | 3,578.74% |
| Dec 31, 2019 | 12.70M | -92.25% |
| Dec 31, 2018 | 163.80M | -19.31% |
| Dec 29, 2017 | 203.00M | -4.92% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences | 21.63M |
| Akso Health Group | 21.59M |
| Cumberland Pharmaceuticals | 21.43M |
| Singular Genomics Systems | 21.41M |
| Viracta Therapeutics | 21.09M |
| Aptorum Group | 20.99M |
| Apollomics | 20.63M |
| NanoViricides | 20.60M |